Creating New Possibilities

While we first learned about cellular regulation by molecular networks nearly 50 years ago, synthetic biology as a field has emerged in just the last 15 years. The rise of high throughput biology, advances in DNA sequencing and synthesis, understanding of gene regulators and sensors, and the development of computational models and logic, have enabled the birth of a new area of science with tremendous promise and many potential applications. Scientists now have the ability to write genetic code or sequences to build biological systems, new living organisms programmed with specific functions. Already, designed or engineered bacteria have contributed to significant advances in agriculture and biofuels.

Synlogic is pioneering synthetic biology in medicine, designing first-in-class biotherapeutics to treat disease in new ways. Synthetic Biotics are living organisms designed to impact specific functions in the body to treat disease.

From Progress to Promise

Brendan St. Amant

Brendan joined Synlogic in 2021 as Vice President, Head of Legal. Prior to joining Synlogic, he was Vice President, Legal, and member of the leadership team at Ohana Biosciences and was senior counsel at Vertex Pharmaceuticals. Brendan was previously an associate and partner at the law firm of Donnelly, Conroy & Gelhaar, LLP, in Boston where he focused on commercial controversies and government enforcement. Earlier in his legal career, Brendan served as a clerk for the U.S. District Court for the District of Connecticut and was an associate at the law firm of Goodwin Procter. He received his B.A. in History from Cornell University, J.D. from Harvard Law School, and his M.P.P from the Harvard Kennedy School. Brendan has served on several practice-related bar committees and on the executive committee of the Board of Trustees of the Massachusetts Continuing Legal Education corporation. 

Interested in receiving news and updates about our work?

Sign up to stay connected.

Yes, pease keep me informed about Synlogic’s research, news and education activities.

By clicking above, I agree that Synlogic may send me information about the company and its programs, and that I have read, understood, and agree to the collection and use of my information as described in Synlogic’s privacy policy.

I can unsubscribe at any time by emailing patients@synlogictx.com with “Unsubscribe”.